SICAGEN INDIA
|
|
BOM : 533014     NSE : SICAGEN     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Dec 04,2024 |
Price(EOD): ₹ 83.73
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Trading |
MCap: ₹ 331.57 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SICAGEN INDIA | 5.4% | -3.3% | 42.6% |
ADANI ENTERPRISES | 2.4% | -15.3% | 6.5% |
REDINGTON | 5.3% | 6.6% | 27.6% |
HONASA CONSUMER | 10.7% | -29.6% | -36.7% |
MMTC | 0.7% | 0.2% | 60% |
MSTC | 0.2% | 9% | 74% |
LLOYDS ENTERPRISES | 6.6% | 2.2% | 31.1% |
VERITAS (INDIA) | 5.5% | -5.3% | 159% |
NOVARTIS INDIA | 0.1% | -2.1% | 51.3% |
FUNDAMENTAL ANALYSIS OF SICAGEN INDIA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SICAGEN INDIA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
23.12
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 14.33 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 0.72
P/B Calculated based on Book Value of Rs 459.75 Cr
[Latest Year - Mar2024 - Consolidated Results ] 0.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 878.91 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
452% 529% 256% |
SHARE PRICE MOMENTUM OF SICAGEN INDIA
SICAGEN INDIA vs SENSEX
DEBT OF SICAGEN INDIA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.1 0.11 0.08 0.1 |
0.23 0.24 0.19 0.22 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SICAGEN INDIA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SICAGEN INDIA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-14.88% -10.79% -8.45% -13.75% |
9.79% 61.84% 191.05% 218.46% |
QtrlyTrend |
0 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
SICAGEN INDIA related INDICES
You may also like the below Video Courses
FAQ about SICAGEN INDIA
Is SICAGEN INDIA good for long term investment?
As on Dec 04,2024, the Fundamentals of SICAGEN INDIA look Poor and hence it may not be good for long term investment ! See Financial Performance of SICAGEN INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SICAGEN INDIA UnderValued or OverValued?
As on Dec 04,2024, SICAGEN INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SICAGEN INDIA ?
As on Dec 04,2024, the Intrinsic Value of SICAGEN INDIA is Rs. 15.16 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 15.16
Fair Value [Median EV / Sales Model] : Rs. 13.32
Fair Value [Median Price / Sales Model] : Rs. 23.52
Estimated Median Fair Value of SICAGEN INDIA : Rs. 15.16
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is SICAGEN INDIA trading at a Premium or Discount?
As on Dec 04,2024, SICAGEN INDIA is trading at a Premium of 452% based on the estimates of Median Intrinsic Value!ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs LLOYDS ENTERPRISES LTD